Advertisement
Advertisement

ANAB

ANAB logo

AnaptysBio Inc

16.44
USD
+0.445
+2.78%
Dec 18, 14:07 UTC -5
Open

AnaptysBio Inc Profile

About

AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California.

Info & Links

CEO

Daniel Faga

Headquarters

10770 WATERIDGE CIRCLE, SUITE 210
SAN DIEGO, CA 92121, UNITED STATES

Auditor

KPMG LLP

Share holders

10

Employees

117

AnaptysBio Inc Statistics

Valuation Measures

Market Capitalization2

500.12M

Enterprise Value

308.54M

Enterprise Value/EBITDA(ttm)

-1.98

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

8.30

Price to Book(mrq)

5.62

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-289.75%

Profit Margin(ttm)

-403.88%

Return on Equity(ttm)

-287.94%

Return on Invested Capital(ttm)

-651.12%

Return on Assets(ttm)

-37.25%

Income Statement

Revenue(ttm)

57.17M

Revenue Per Share(ttm)

1.88

Gross Profit(ttm)

57.17M

EBITDA(ttm)3

-156.18M

Net Income Available to Common(ttm)

-165.66M

Diluted EPS(ttm)

-6.08

Share Statistics

Beta (5Y Monthly)

-0.11

52-Week Change

5.42%

S&P 500 52-Week Change

27.88%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

30.43M

Dividend Yield

0.00%

Float4

20.17M

% Held by Insiders

33.70%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

430.12M

Total Cash Per Share(mrq)

14.14

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

10.23%

Quick Ratio(mrq)

10.23%

Book Value Per Share(mrq)

2.77

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.38

Free Cash Flow(ytd)

-68.76M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement